Identification of protein interfaces between α-synuclein, the principal component of Lewy bodies in Parkinson disease, and the molecular chaperones human Hsc70 and the yeast Ssa1p.
Identifieur interne : 000517 ( Hal/Curation ); précédent : 000516; suivant : 000518Identification of protein interfaces between α-synuclein, the principal component of Lewy bodies in Parkinson disease, and the molecular chaperones human Hsc70 and the yeast Ssa1p.
Auteurs : Virginie Redeker [France] ; Samantha Pemberton [France] ; Willy Bienvenut [France] ; Luc Bousset [France] ; Ronald Melki [France]Source :
- Journal of Biological Chemistry [ 0021-9258 ] ; 2012-09-21.
Abstract
Fibrillar α-synuclein (α-Syn) is the principal component of Lewy bodies, which are evident in individuals affected by Parkinson disease (PD). This neuropathologic form of α-Syn plays a central role in PD progression as it has been shown to propagate between neurons. Tools that interfere with α-Syn assembly or change the physicochemical properties of the fibrils have potential therapeutic properties as they may be sufficient to interfere with and/or halt cell-to-cell transmission and the systematic spread of α-Syn assemblies within the central nervous system. Vertebrate molecular chaperones from the constitutive/heat-inducible heat shock protein 70 (Hsc/p70) family have been shown to hinder the assembly of soluble α-Syn into fibrils and to bind to the fibrils and very significantly reduce their toxicity. To understand how Hsc70 family members sequester soluble α-Syn, we set up experiments to identify the molecular chaperone-α-Syn surface interfaces. We cross-linked human Hsc70 and its yeast homologue Ssa1p and α-Syn using a chemical cross-linker and mapped the Hsc70- and Ssa1p-α-Syn interface. We show that the client binding domain of Hsc70 and Ssa1p binds two regions within α-Syn similar to a tweezer, with the first spanning residues 10-45 and the second spanning residues 97-102. Our findings define what is necessary and sufficient for engineering Hsc70- and Ssa1p-derived polypeptide with minichaperone properties with a potential as therapeutic agents in Parkinson disease through their ability to affect α-Syn assembly and/or toxicity.
Url:
DOI: 10.1074/jbc.M112.387530
Links toward previous steps (curation, corpus...)
- to stream Hal, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000540
Links to Exploration step
Hal:hal-01183065Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Identification of protein interfaces between α-synuclein, the principal component of Lewy bodies in Parkinson disease, and the molecular chaperones human Hsc70 and the yeast Ssa1p.</title>
<author><name sortKey="Redeker, Virginie" sort="Redeker, Virginie" uniqKey="Redeker V" first="Virginie" last="Redeker">Virginie Redeker</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-84651" status="VALID"> <orgName>Laboratoire d'Enzymologie et Biochimie Structurales</orgName>
<orgName type="acronym">LEBS</orgName>
<desc> <address> <addrLine>91 198 Gif-sur-Yvette Cedex</addrLine>
<country key="FR"></country>
</address>
</desc>
<listRelation> <relation name="UPR3082" active="#struct-441569" type="direct"></relation>
</listRelation>
<tutelles><tutelle name="UPR3082" active="#struct-441569" type="direct"><org type="institution" xml:id="struct-441569" status="VALID"> <idno type="IdRef">02636817X</idno>
<idno type="ISNI">0000000122597504</idno>
<orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<date type="start">1939-10-19</date>
<desc> <address> <country key="FR"></country>
</address>
<ref type="url">http://www.cnrs.fr/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Pemberton, Samantha" sort="Pemberton, Samantha" uniqKey="Pemberton S" first="Samantha" last="Pemberton">Samantha Pemberton</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-84651" status="VALID"> <orgName>Laboratoire d'Enzymologie et Biochimie Structurales</orgName>
<orgName type="acronym">LEBS</orgName>
<desc> <address> <addrLine>91 198 Gif-sur-Yvette Cedex</addrLine>
<country key="FR"></country>
</address>
</desc>
<listRelation> <relation name="UPR3082" active="#struct-441569" type="direct"></relation>
</listRelation>
<tutelles><tutelle name="UPR3082" active="#struct-441569" type="direct"><org type="institution" xml:id="struct-441569" status="VALID"> <idno type="IdRef">02636817X</idno>
<idno type="ISNI">0000000122597504</idno>
<orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<date type="start">1939-10-19</date>
<desc> <address> <country key="FR"></country>
</address>
<ref type="url">http://www.cnrs.fr/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Bienvenut, Willy" sort="Bienvenut, Willy" uniqKey="Bienvenut W" first="Willy" last="Bienvenut">Willy Bienvenut</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-84651" status="VALID"> <orgName>Laboratoire d'Enzymologie et Biochimie Structurales</orgName>
<orgName type="acronym">LEBS</orgName>
<desc> <address> <addrLine>91 198 Gif-sur-Yvette Cedex</addrLine>
<country key="FR"></country>
</address>
</desc>
<listRelation> <relation name="UPR3082" active="#struct-441569" type="direct"></relation>
</listRelation>
<tutelles><tutelle name="UPR3082" active="#struct-441569" type="direct"><org type="institution" xml:id="struct-441569" status="VALID"> <idno type="IdRef">02636817X</idno>
<idno type="ISNI">0000000122597504</idno>
<orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<date type="start">1939-10-19</date>
<desc> <address> <country key="FR"></country>
</address>
<ref type="url">http://www.cnrs.fr/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Bousset, Luc" sort="Bousset, Luc" uniqKey="Bousset L" first="Luc" last="Bousset">Luc Bousset</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-84651" status="VALID"> <orgName>Laboratoire d'Enzymologie et Biochimie Structurales</orgName>
<orgName type="acronym">LEBS</orgName>
<desc> <address> <addrLine>91 198 Gif-sur-Yvette Cedex</addrLine>
<country key="FR"></country>
</address>
</desc>
<listRelation> <relation name="UPR3082" active="#struct-441569" type="direct"></relation>
</listRelation>
<tutelles><tutelle name="UPR3082" active="#struct-441569" type="direct"><org type="institution" xml:id="struct-441569" status="VALID"> <idno type="IdRef">02636817X</idno>
<idno type="ISNI">0000000122597504</idno>
<orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<date type="start">1939-10-19</date>
<desc> <address> <country key="FR"></country>
</address>
<ref type="url">http://www.cnrs.fr/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Melki, Ronald" sort="Melki, Ronald" uniqKey="Melki R" first="Ronald" last="Melki">Ronald Melki</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-84651" status="VALID"> <orgName>Laboratoire d'Enzymologie et Biochimie Structurales</orgName>
<orgName type="acronym">LEBS</orgName>
<desc> <address> <addrLine>91 198 Gif-sur-Yvette Cedex</addrLine>
<country key="FR"></country>
</address>
</desc>
<listRelation> <relation name="UPR3082" active="#struct-441569" type="direct"></relation>
</listRelation>
<tutelles><tutelle name="UPR3082" active="#struct-441569" type="direct"><org type="institution" xml:id="struct-441569" status="VALID"> <idno type="IdRef">02636817X</idno>
<idno type="ISNI">0000000122597504</idno>
<orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<date type="start">1939-10-19</date>
<desc> <address> <country key="FR"></country>
</address>
<ref type="url">http://www.cnrs.fr/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">HAL</idno>
<idno type="RBID">Hal:hal-01183065</idno>
<idno type="halId">hal-01183065</idno>
<idno type="halUri">https://hal.archives-ouvertes.fr/hal-01183065</idno>
<idno type="url">https://hal.archives-ouvertes.fr/hal-01183065</idno>
<idno type="doi">10.1074/jbc.M112.387530</idno>
<date when="2012-09-21">2012-09-21</date>
<idno type="wicri:Area/Hal/Corpus">000540</idno>
<idno type="wicri:Area/Hal/Curation">000540</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Identification of protein interfaces between α-synuclein, the principal component of Lewy bodies in Parkinson disease, and the molecular chaperones human Hsc70 and the yeast Ssa1p.</title>
<author><name sortKey="Redeker, Virginie" sort="Redeker, Virginie" uniqKey="Redeker V" first="Virginie" last="Redeker">Virginie Redeker</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-84651" status="VALID"> <orgName>Laboratoire d'Enzymologie et Biochimie Structurales</orgName>
<orgName type="acronym">LEBS</orgName>
<desc> <address> <addrLine>91 198 Gif-sur-Yvette Cedex</addrLine>
<country key="FR"></country>
</address>
</desc>
<listRelation> <relation name="UPR3082" active="#struct-441569" type="direct"></relation>
</listRelation>
<tutelles><tutelle name="UPR3082" active="#struct-441569" type="direct"><org type="institution" xml:id="struct-441569" status="VALID"> <idno type="IdRef">02636817X</idno>
<idno type="ISNI">0000000122597504</idno>
<orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<date type="start">1939-10-19</date>
<desc> <address> <country key="FR"></country>
</address>
<ref type="url">http://www.cnrs.fr/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Pemberton, Samantha" sort="Pemberton, Samantha" uniqKey="Pemberton S" first="Samantha" last="Pemberton">Samantha Pemberton</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-84651" status="VALID"> <orgName>Laboratoire d'Enzymologie et Biochimie Structurales</orgName>
<orgName type="acronym">LEBS</orgName>
<desc> <address> <addrLine>91 198 Gif-sur-Yvette Cedex</addrLine>
<country key="FR"></country>
</address>
</desc>
<listRelation> <relation name="UPR3082" active="#struct-441569" type="direct"></relation>
</listRelation>
<tutelles><tutelle name="UPR3082" active="#struct-441569" type="direct"><org type="institution" xml:id="struct-441569" status="VALID"> <idno type="IdRef">02636817X</idno>
<idno type="ISNI">0000000122597504</idno>
<orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<date type="start">1939-10-19</date>
<desc> <address> <country key="FR"></country>
</address>
<ref type="url">http://www.cnrs.fr/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Bienvenut, Willy" sort="Bienvenut, Willy" uniqKey="Bienvenut W" first="Willy" last="Bienvenut">Willy Bienvenut</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-84651" status="VALID"> <orgName>Laboratoire d'Enzymologie et Biochimie Structurales</orgName>
<orgName type="acronym">LEBS</orgName>
<desc> <address> <addrLine>91 198 Gif-sur-Yvette Cedex</addrLine>
<country key="FR"></country>
</address>
</desc>
<listRelation> <relation name="UPR3082" active="#struct-441569" type="direct"></relation>
</listRelation>
<tutelles><tutelle name="UPR3082" active="#struct-441569" type="direct"><org type="institution" xml:id="struct-441569" status="VALID"> <idno type="IdRef">02636817X</idno>
<idno type="ISNI">0000000122597504</idno>
<orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<date type="start">1939-10-19</date>
<desc> <address> <country key="FR"></country>
</address>
<ref type="url">http://www.cnrs.fr/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Bousset, Luc" sort="Bousset, Luc" uniqKey="Bousset L" first="Luc" last="Bousset">Luc Bousset</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-84651" status="VALID"> <orgName>Laboratoire d'Enzymologie et Biochimie Structurales</orgName>
<orgName type="acronym">LEBS</orgName>
<desc> <address> <addrLine>91 198 Gif-sur-Yvette Cedex</addrLine>
<country key="FR"></country>
</address>
</desc>
<listRelation> <relation name="UPR3082" active="#struct-441569" type="direct"></relation>
</listRelation>
<tutelles><tutelle name="UPR3082" active="#struct-441569" type="direct"><org type="institution" xml:id="struct-441569" status="VALID"> <idno type="IdRef">02636817X</idno>
<idno type="ISNI">0000000122597504</idno>
<orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<date type="start">1939-10-19</date>
<desc> <address> <country key="FR"></country>
</address>
<ref type="url">http://www.cnrs.fr/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Melki, Ronald" sort="Melki, Ronald" uniqKey="Melki R" first="Ronald" last="Melki">Ronald Melki</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-84651" status="VALID"> <orgName>Laboratoire d'Enzymologie et Biochimie Structurales</orgName>
<orgName type="acronym">LEBS</orgName>
<desc> <address> <addrLine>91 198 Gif-sur-Yvette Cedex</addrLine>
<country key="FR"></country>
</address>
</desc>
<listRelation> <relation name="UPR3082" active="#struct-441569" type="direct"></relation>
</listRelation>
<tutelles><tutelle name="UPR3082" active="#struct-441569" type="direct"><org type="institution" xml:id="struct-441569" status="VALID"> <idno type="IdRef">02636817X</idno>
<idno type="ISNI">0000000122597504</idno>
<orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<date type="start">1939-10-19</date>
<desc> <address> <country key="FR"></country>
</address>
<ref type="url">http://www.cnrs.fr/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
</analytic>
<idno type="DOI">10.1074/jbc.M112.387530</idno>
<series><title level="j">Journal of Biological Chemistry</title>
<idno type="ISSN">0021-9258</idno>
<imprint><date type="datePub">2012-09-21</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Fibrillar α-synuclein (α-Syn) is the principal component of Lewy bodies, which are evident in individuals affected by Parkinson disease (PD). This neuropathologic form of α-Syn plays a central role in PD progression as it has been shown to propagate between neurons. Tools that interfere with α-Syn assembly or change the physicochemical properties of the fibrils have potential therapeutic properties as they may be sufficient to interfere with and/or halt cell-to-cell transmission and the systematic spread of α-Syn assemblies within the central nervous system. Vertebrate molecular chaperones from the constitutive/heat-inducible heat shock protein 70 (Hsc/p70) family have been shown to hinder the assembly of soluble α-Syn into fibrils and to bind to the fibrils and very significantly reduce their toxicity. To understand how Hsc70 family members sequester soluble α-Syn, we set up experiments to identify the molecular chaperone-α-Syn surface interfaces. We cross-linked human Hsc70 and its yeast homologue Ssa1p and α-Syn using a chemical cross-linker and mapped the Hsc70- and Ssa1p-α-Syn interface. We show that the client binding domain of Hsc70 and Ssa1p binds two regions within α-Syn similar to a tweezer, with the first spanning residues 10-45 and the second spanning residues 97-102. Our findings define what is necessary and sufficient for engineering Hsc70- and Ssa1p-derived polypeptide with minichaperone properties with a potential as therapeutic agents in Parkinson disease through their ability to affect α-Syn assembly and/or toxicity.</div>
</front>
</TEI>
<hal api="V3"> <titleStmt> <title xml:lang="en">Identification of protein interfaces between α-synuclein, the principal component of Lewy bodies in Parkinson disease, and the molecular chaperones human Hsc70 and the yeast Ssa1p.</title>
<author role="aut"> <persName> <forename type="first">Virginie</forename>
<surname>Redeker</surname>
</persName>
<idno type="halauthorid">127279</idno>
<affiliation ref="#struct-84651"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">Samantha</forename>
<surname>Pemberton</surname>
</persName>
<idno type="halauthorid">561372</idno>
<affiliation ref="#struct-84651"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">Willy</forename>
<surname>Bienvenut</surname>
</persName>
<idno type="halauthorid">1194935</idno>
<affiliation ref="#struct-84651"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">Luc</forename>
<surname>Bousset</surname>
</persName>
<idno type="halauthorid">190085</idno>
<affiliation ref="#struct-84651"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">Ronald</forename>
<surname>Melki</surname>
</persName>
<idno type="halauthorid">190086</idno>
<affiliation ref="#struct-84651"></affiliation>
</author>
<editor role="depositor"> <persName> <forename>Alain</forename>
<surname>PERIGNON</surname>
</persName>
<email type="md5">0915a8bc0b5a494fc86eb9724296445c</email>
<email type="domain">cnrs.fr</email>
</editor>
</titleStmt>
<editionStmt> <edition n="v1" type="current"> <date type="whenSubmitted">2015-08-06 10:37:25</date>
<date type="whenModified">2016-07-27 14:48:27</date>
<date type="whenReleased">2015-08-06 10:37:25</date>
<date type="whenProduced">2012-09-21</date>
</edition>
<respStmt> <resp>contributor</resp>
<name key="108746"> <persName> <forename>Alain</forename>
<surname>PERIGNON</surname>
</persName>
<email type="md5">0915a8bc0b5a494fc86eb9724296445c</email>
<email type="domain">cnrs.fr</email>
</name>
</respStmt>
</editionStmt>
<publicationStmt> <distributor>CCSD</distributor>
<idno type="halId">hal-01183065</idno>
<idno type="halUri">https://hal.archives-ouvertes.fr/hal-01183065</idno>
<idno type="halBibtex">redeker:hal-01183065</idno>
<idno type="halRefHtml">Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, 2012, 287 (39), pp.32630-9. <10.1074/jbc.M112.387530></idno>
<idno type="halRef">Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, 2012, 287 (39), pp.32630-9. <10.1074/jbc.M112.387530></idno>
</publicationStmt>
<seriesStmt> <idno type="stamp" n="CNRS">CNRS - Centre national de la recherche scientifique</idno>
</seriesStmt>
<notesStmt> <note type="audience" n="2">International</note>
<note type="popular" n="0">No</note>
<note type="peer" n="1">Yes</note>
</notesStmt>
<sourceDesc> <biblStruct> <analytic> <title xml:lang="en">Identification of protein interfaces between α-synuclein, the principal component of Lewy bodies in Parkinson disease, and the molecular chaperones human Hsc70 and the yeast Ssa1p.</title>
<author role="aut"> <persName> <forename type="first">Virginie</forename>
<surname>Redeker</surname>
</persName>
<idno type="halauthorid">127279</idno>
<affiliation ref="#struct-84651"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">Samantha</forename>
<surname>Pemberton</surname>
</persName>
<idno type="halauthorid">561372</idno>
<affiliation ref="#struct-84651"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">Willy</forename>
<surname>Bienvenut</surname>
</persName>
<idno type="halauthorid">1194935</idno>
<affiliation ref="#struct-84651"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">Luc</forename>
<surname>Bousset</surname>
</persName>
<idno type="halauthorid">190085</idno>
<affiliation ref="#struct-84651"></affiliation>
</author>
<author role="aut"> <persName> <forename type="first">Ronald</forename>
<surname>Melki</surname>
</persName>
<idno type="halauthorid">190086</idno>
<affiliation ref="#struct-84651"></affiliation>
</author>
</analytic>
<monogr> <idno type="halJournalId" status="VALID">5882</idno>
<idno type="issn">0021-9258</idno>
<idno type="eissn">1083-351X</idno>
<title level="j">Journal of Biological Chemistry</title>
<imprint> <publisher>American Society for Biochemistry and Molecular Biology</publisher>
<biblScope unit="volume">287</biblScope>
<biblScope unit="issue">39</biblScope>
<biblScope unit="pp">32630-9</biblScope>
<date type="datePub">2012-09-21</date>
</imprint>
</monogr>
<idno type="doi">10.1074/jbc.M112.387530</idno>
<idno type="pubmed">22843682</idno>
<idno type="pubmedcentral">PMC3463349</idno>
</biblStruct>
</sourceDesc>
<profileDesc> <langUsage> <language ident="en">English</language>
</langUsage>
<textClass> <classCode scheme="mesh">Adenosine Triphosphatases</classCode>
<classCode scheme="mesh">HSC70 Heat-Shock Proteins</classCode>
<classCode scheme="mesh">Saccharomyces cerevisiae</classCode>
<classCode scheme="mesh">Saccharomyces cerevisiae Proteins</classCode>
<classCode scheme="mesh">Solubility</classCode>
<classCode scheme="mesh">alpha-Synuclein</classCode>
<classCode scheme="mesh">HSP70 Heat-Shock Proteins</classCode>
<classCode scheme="mesh">Humans</classCode>
<classCode scheme="mesh">Lewy Bodies</classCode>
<classCode scheme="mesh">Parkinson Disease</classCode>
<classCode scheme="mesh">Peptides</classCode>
<classCode scheme="mesh">Protein Binding</classCode>
<classCode scheme="mesh">Protein Engineering</classCode>
<classCode scheme="mesh">Protein Structure, Tertiary</classCode>
<classCode scheme="halDomain" n="sdv.neu.nb">Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Neurobiology</classCode>
<classCode scheme="halDomain" n="sdv.neu.pc">Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Psychology and behavior</classCode>
<classCode scheme="halDomain" n="sdv.neu.sc">Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Cognitive Sciences</classCode>
<classCode scheme="halTypology" n="ART">Journal articles</classCode>
</textClass>
<abstract xml:lang="en">Fibrillar α-synuclein (α-Syn) is the principal component of Lewy bodies, which are evident in individuals affected by Parkinson disease (PD). This neuropathologic form of α-Syn plays a central role in PD progression as it has been shown to propagate between neurons. Tools that interfere with α-Syn assembly or change the physicochemical properties of the fibrils have potential therapeutic properties as they may be sufficient to interfere with and/or halt cell-to-cell transmission and the systematic spread of α-Syn assemblies within the central nervous system. Vertebrate molecular chaperones from the constitutive/heat-inducible heat shock protein 70 (Hsc/p70) family have been shown to hinder the assembly of soluble α-Syn into fibrils and to bind to the fibrils and very significantly reduce their toxicity. To understand how Hsc70 family members sequester soluble α-Syn, we set up experiments to identify the molecular chaperone-α-Syn surface interfaces. We cross-linked human Hsc70 and its yeast homologue Ssa1p and α-Syn using a chemical cross-linker and mapped the Hsc70- and Ssa1p-α-Syn interface. We show that the client binding domain of Hsc70 and Ssa1p binds two regions within α-Syn similar to a tweezer, with the first spanning residues 10-45 and the second spanning residues 97-102. Our findings define what is necessary and sufficient for engineering Hsc70- and Ssa1p-derived polypeptide with minichaperone properties with a potential as therapeutic agents in Parkinson disease through their ability to affect α-Syn assembly and/or toxicity.</abstract>
</profileDesc>
</hal>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Hal/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000517 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Hal/Curation/biblio.hfd -nk 000517 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= ParkinsonFranceV1 |flux= Hal |étape= Curation |type= RBID |clé= Hal:hal-01183065 |texte= Identification of protein interfaces between α-synuclein, the principal component of Lewy bodies in Parkinson disease, and the molecular chaperones human Hsc70 and the yeast Ssa1p. }}
![]() | This area was generated with Dilib version V0.6.29. | ![]() |